tilavonemab (ABBV-8E12) - AbbVie
http://www.ncbi.nlm.nih.gov/pubmed/38835820
 
Anatoli Yashin; Haotian Zou; Igor Akushevich; Kathleen A Welsh-Bohmer; Konstantin Arbeev; Michael W Lutz; Sheng Luo; Xiaoxiao Zhou
 
Jun 5, 2024
 
Prev Next